AASLD Leads the Way in Cutting-Edge Education on Metabolic Dysfunction Associated Steatotic Liver Disease

Alexandria, VA – Join Program Chairs Anna Mae Diehl, MD, FAASLD, Mazen Noureddin, MD, MHSc, and AASLD President Ray Kim, MD, MBA, FAASLD to learn about the latest groundbreaking discoveries and practical treatment methods for Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) at the AASLD Emerging Topic Conference (ETC): Precision Medicine in MASLD held on March 8-9 in Las Vegas, NV. 

This event unites physicians, scientists, and allied health professionals at the forefront of Precision Medicine in MASLD. The conference aims to evaluate the role of OMICs technologies in relation to MASLD care, explore novel ‘wet’ and ‘dry’ biomarkers in diagnosis and risk assessment, and uncover strategies and best practices for applying precision medicine, amongst other topics. View the two-day program

AASLD and its members are proud to have been one of the leading multinational liver societies that developed and finalized the new NAFLD nomenclature for liver disease, which was announced in June 2023: Steatotic Liver Disease. AASLD is committed to providing extensive resources and cutting-edge educational opportunities, including the upcoming Emerging Topic Conference that will provide attendees with the latest information on precision medicine in MASLD.   


Program Chairs:  
Anna Mae Diehl, MD, FAASLD 
Mazen Noureddin, MD, MHSc 
W. Ray Kim, MD, MBA, FAASLD 


Alina Allen, MD 
Arun Sanyal, MD, FAASLD 
Cynthia Behling, MD, PhD 
Dina Tiniakos, MD, PhD, FRCPath 
Elisabeth Bugianesi, MD, PhD 
Jasmohan Bajaj, MD, FAASLD 
Kathleen Corey, MD, MPH, MMSc 
Lisa VanWagner, MD, MS 
Liz Speliotes, MD, PhD, MPH 
Mary E. Rinella, MD, FAASLD 
Meena Bansal, MD, FAASLD 
Megan Gray, MD 
Michelle Long, MD, MSc 
Mustafa Bashir, MD 
Naga Chalasani, MD, FAASLD 
Quentin Anstee, MBBS, PhD, FRCP 
Rohit Loomba, MD, MHSc, FAASLD 
Sam Klein, MD 
Samer Gawrieh, MD 
Silvia Sookoian, MD, PhD, FAASLD 
Stephen Harrison, MD, FAASLD 
Vincent Wong, MD 
Yaron Rotman, MD, MSc, FAASLD 




About AASLD 

AASLD is the leading organization of clinicians, researchers and allied health professionals committed to preventing and curing liver disease. The work of our members has laid the foundation for the development of drugs used to treat patients with viral hepatitis. Access to care and support of liver disease research are at the center of AASLD’s advocacy efforts. To learn more, visit www.aasld.org.